[Table/Fig-1]:
Clinicopathological data on patients diagnosed with small cell carcinoma of the esophagus
| Case | Age (years) | Sex | Symptoms | Endoscopy | Location in the esophagus | Secondaries | Immuno-histochemistry positivity | Associated lesion | Treatment | Follow up |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 60 | M | Dysphagia + weight loss | Ulcero-proliferative growth | Mid third | Squamous cell carcinoma | - | - | ||
| 2 | 50 | M | Dysphagia | Ulcerated growth | Mid third | None | Synaptophysin | None | CT+RT | |
| 3 | 76 | F | Abdominal pain | Ulcero-proliferative growth | Mid third | Liver+ abdominal lymph Nodes | Squamous cell carcinoma in situ | |||
| 4 | 70 | M | Vomiting | Ulcerated growth | Upper third | Liver | Synaptophysin, CK | |||
| 5 | 40 | M | Dysphagia + weight loss | Ulceroproliferative growth | Mid third | Abdominal lymph Node | Synaptophysin | CT | Alive after 1 year | |
| 6 | 60 | M | Dysphagia | Ulceroproliferative growth | Mid third | Synaptophysin | Squamous dysplasia | |||
| 7 | 58 | M | Dysphagia | Ulceroproliferative growth | Upper third | Liver+ Bone | Chromgranin, Synaptophysin | Squamous dysplasia | CT+RT | |
| 8 | 55 | M | Dysphagia | Ulceroproliferative growth | Upper third | Paraesophageal lymph Node + Bone + lungs | Chromgranin, Synaptophysin | Squamous cell carcinoma | CT+RT | Alive after 1 year |
| 9 | 68 | M | Dysphagia + abdominal pain | Ulcer | Lower third | Liver +abdominal lymphnodes + lungs | Chromgranin, Synaptophysin | CT | ||
| 10 | 62 | F | Dysphagia + abdominal pain | Ulceroproliferative growth | Mid third | Liver | Chromogranin, Synaptophysin | CT | ||
| 11 | 67 | M | Abdominal pain | Ulceroproliferative growth | Mid third | Liver+bone+ abdominal lymph nodes | Synaptophysin |
M = male; F = female; CT = chemotherapy; RT = radiotherapy; CK = cytokeratin